CI/SDVEssai enregistréTerminé

Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS

L'essai en bref

Approche testée
neuromodulation tibiale, neuromodulation sacrée
Pays
United States
Participants
16 participants · femmes
Début
1 juin 2015
Fin prévue
1 mars 2018
Dernière mise à jour du registre
27 juillet 2023
Promoteur
University of California, Irvine
Identifiant du registre
NCT02550561

Notre articleCystite interstitielle : où en sont les essais cliniques dans le monde ? (octobre 2026)

Lire notre article
Résumé officiel (en anglais)
In 2014, the American Urological Association updated it management algorithm for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). As the algorithm progresses, interventions become increasingly invasive and morbid. 4th line treatment is sacral neuromodulation (SNM), involving a two stage surgical procedure and permanent device implantation. While the mechanism for decrease in IC/PBS symptoms is unknown, SNM is thought act through central and peripheral mechanisms related to afferent signaling, causing modification of pain and lower urinary tract sensation.¹ Percutaneous posterior tibial nerve stimulation (PTNS) is a method of peripheral neuromodulation targeting the same nerve roots as SNM, but with significantly fewer risks. The purpose of our research is to determine if PTNS is effective in the treatment of IC/PBS. The results of this study will suggest future directions and provide critical information to design studies to determine to what extent and in what situations PTNS may be effective. The investigators will enroll subjects with IC/PBS and urinary frequency/urgency to treatment with 12 weekly treatments of PTNS. The investigators will assess symptoms and lower urinary tract function before, during and after the treatments. At the completion of treatments, subjects will be asked to enroll in post-study follow up monitoring to understand the duration of symptom effect.

Information sur la recherche, à but informatif. Elle ne constitue pas un avis médical : parlez-en avec votre médecin.

Retour aux études suivies
Rejoindre la bêta →